Bus, P., Scharpfenecker, M., Van Der Wilk, P., Wolterbeek, R., Bruijn, J. A., & Baelde, H. J. (2017). The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes. Diabetologia.

Bus, Pascal, Marion Scharpfenecker, Priscilla Van Der Wilk, Ron Wolterbeek, Jan A. Bruijn, και Hans J. Baelde. "The VEGF-A Inhibitor SFLT-1 Improves Renal Function By Reducing Endothelial Activation and Inflammation in a Mouse Model of Type 1 Diabetes." Diabetologia 2017.

Bus, Pascal, et al. "The VEGF-A Inhibitor SFLT-1 Improves Renal Function By Reducing Endothelial Activation and Inflammation in a Mouse Model of Type 1 Diabetes." Diabetologia 2017.